International Journal of Scientific Research in Dental and Medical Sciences

International Journal of Scientific Research in Dental and Medical Sciences

Navigating Diagnostic Challenges in Pulmonary Aspergillosis: A Case Series Demonstrating the Synergy of Investigation Techniques

Document Type : Case Reports

Authors
1 Department of Microbiology , Sree Narayana Institute of Medical Sciences, Kerala University of Health Sciences, Ernakulam, India
2 Department of Medicine, Sree Narayana Institute of Medical Sciences, Kerala University of Health Sciences, Ernakulam, India
Abstract
Aspergillosis encompasses a spectrum of diseases caused by Aspergillus species, with pulmonary aspergillosis being a significant concern due to its increasing incidence and impact on both immunocompromised and immunocompetent individuals. The most prevalent chronic form, chronic cavitary pulmonary aspergillosis (CCPA), can progress to chronic fibrosing pulmonary aspergillosis if left untreated, highlighting the need for accurate and timely diagnosis. Diagnosis of pulmonary aspergillosis relies on a multi-faceted approach. While microscopy, especially with fluorescent dyes, allows for the rapid detection of fungal elements in samples like BAL, it lacks sensitivity and specificity for Aspergillus. Similarly, microscopy of sputum, although useful for initial assessment, has a sensitivity of only 50%. Culture, despite lower-than-expected sensitivity from sputum samples, remains essential for definitive diagnosis and management. It not only confirms the presence of Aspergillus but also critically enables antifungal susceptibility testing,  guiding appropriate treatment. Culture, despite limitations, should be prioritized to ensure accurate species identification and susceptibility profiling, facilitating targeted and effective treatment strategies.
Keywords

Subjects


[1] Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clinical Microbiology and Infection. 2018;24:e1-38. https://doi.org/10.1016/j.cmi.2018.01.002.
[2] Hage CA, Carmona EM, Epelbaum O, Evans SE, Gabe LM, Haydour Q, et al. Microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice. An official American Thoracic Society clinical practice guideline. American journal of respiratory and critical care medicine. 2019;200(5):535-50. https://doi.org/10.1164/rccm.201906-1185ST.
[3] Mahajan M, Prasanna S, Das NK, Mahajan N. Case series of invasive lung infections by Aspergillus species and zygomycosis among post COVID-19 and post-transplant individuals. Journal of Family Medicine and Primary Care. 2022;11(11):7469-75. https://doi.org/10.4103/jfmpc.jfmpc_1066_22.
[4] Patterson KC, Strek ME. Diagnosis and treatment of pulmonary aspergillosis syndromes. Chest. 2014;146(5):1358-68. https://doi.org/10.1378/chest.14-0917.
[5] Denning DW, Cadranel J, Beigelman-Aubry C, Ader F, Chakrabarti A, Blot S, et al. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. European Respiratory Journal. 2015;47(1):45-68. https://doi.org/10.1183/13993003.00583-2015.
[6] Marwah V, Choudhary R, Peter D, Bhati G, Kumar K, Akhil R, et al. Chronic pulmonary aspergillosis-case series and review of Indian literature. Indian Journal of Respiratory Care. 2021;10(2):230.
[7] Denning DW, Page ID, Chakaya J, Jabeen K, Jude CM, Cornet M, et al. Case definition of chronic pulmonary aspergillosis in resource-constrained settings. Emerging infectious diseases. 2018;24(8):e171312. https://doi.org/10.3201/eid2408.171312.
Volume 7, Issue 2
Spring 2025
Pages 96-100

  • Receive Date 22 March 2025
  • Revise Date 22 May 2025
  • Accept Date 02 June 2025
  • Publish Date 05 June 2025